Injuries of the Portal Vein in Patients With Blunt Abdominal Trauma

por Henne-Bruns, D., Kremer, B., Lloyd, D. M., Meyer-Pannwitt, U.
Publicado 1993

Detection of the anti-p53 antibody response in malignant and benign pancreatic disease.

por Marxsen, J., Schmiegel, W., Röder, C., Harder, R., Juhl, H., Henne-Bruns, D., Kremer, B., Kalthoff, H.
Publicado 1994

Phase I study of the humanised anti-EGFR monoclonal antibody matuzumab (EMD 72000) combined with gemcitabine in advanced pancreatic cancer

por Graeven, U, Kremer, B, Südhoff, Th, Killing, B, Rojo, F, Weber, D, Tillner, J, ünal, C, Schmiegel, W
Publicado 2006

Swallowing Assessment in Parkinson’s Disease: Patient and Investigator Reported Outcome Measures are not Aligned

por van Hooren, M. R. A., Vos, R., Florie, M. G. M. H., Pilz, W., Kremer, B., Baijens, L. W. J.
Publicado 2020

Feasibility of electronic nose technology for discriminating between head and neck, bladder, and colon carcinomas

por van de Goor, R. M. G. E., Leunis, N., van Hooren, M. R. A., Francisca, E., Masclee, A., Kremer, B., Kross, K. W.
Publicado 2016

Morphological MRI criteria improve the detection of lymph node metastases in head and neck squamous cell carcinoma: multivariate logistic regression analysis of MRI features of cer...

por de Bondt, R. B. J., Nelemans, P. J., Bakers, F., Casselman, J. W., Peutz-Kootstra, C., Kremer, B., Hofman, P. A. M., Beets-Tan, R. G. H.
Publicado 2008

Different prognostic models for different patient populations: validation of a new prognostic model for patients with oropharyngeal cancer in Western Europe

por Rietbergen, M M, Witte, B I, Velazquez, E R, Snijders, P J F, Bloemena, E, Speel, E J, Brakenhoff, R H, Kremer, B, Lambin, P, Leemans, C R
Publicado 2015

P939: SYNERGISTIC EFFECTS OF LOW DOSE BELANTAMAB MAFODOTIN IN COMBINATION WITH A GAMMA-SECRETASE INHIBITOR (NIROGACESTAT) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRM...

por Nooka, A., Lonial, S., Grosicki, S., Hus, M., Song, K., Facon, T., Callander, N. S., Ribrag, V., Uttervall, K., Quach, H., Vorobyev, V., Min, C.-K., Cheng, S., Smith, L. M., Yu, J., Collingwood, T., Holkova, B., Kremer, B. E., Gupta, I. V., Richardson, P. G., Minnema, M. C.
Publicado 2022

P14: DREAMM-9: PHASE I STUDY OF BELANTAMAB MAFODOTIN PLUS STANDARD OF CARE IN PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA

por Usmani, S, Alonso, A, Quach, H, Koh, Y, Guenther, A, Min, CK, Leleu, X, Abdallah, AO, Oriol, A, Bessemer, B, Garg, M, Sandhu, I, Weisel, K, Ocio San Miguel, E, Cavo, M, Zhou, X, Kaisermann, M, Mis, L, Williams, D, Yeakey, A, Ferron-Brady, G, Figueroa, D, Kremer, B, Gupta, I, Janowski, W
Publicado 2022

P942: DREAMM-9: PHASE I STUDY OF BELANTAMAB MAFODOTIN PLUS STANDARD OF CARE IN PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA

por Usmani, S. Z., Mielnik, M., Koh, Y., Alonso Alonso, A., Leleu, X., Quach, H., Min, C.-K., Janowski, W., Abdallah, A.-O., Garg, M., Sandhu, I., Ocio San Miguel, E. M., Oriol, A., Rodriquez-Otero, P., Ramasamy, K., Weisel, K., Besemer, B., Cavo, M., Zhou, X. L., Kaisermann, M. C., Bego Marques, C. M., Williams, D., Carreno, F., Kremer, B. E., Gupta, I. V., Hus, M.
Publicado 2022